Fluidx Medical Technology, Inc., released information regarding the success of the IMPASS Embolic Device in in-vivo research related to middle meningeal artery (MMA) embolizations which can be used to treat chronic subdural hematomas (CSDH) on the surface of the brain. CSDH is a common pathology encountered that can result in death and/or disability in patients. The typical treatment of CSDH involves drilling a hole in the skull and draining the blood. Minimally invasive catheter-based MMA embolization can be an alternative…

PainChek, developer of a smartphone-based pain assessment and monitoring application, has partnered with InterSystems IRIS for Health to integrate its application with electronic medical record (EMR) systems. Combining the companies' platforms will facilitate PainChek's hospital global market entry as it aims to transform pain management in the hospital sector. PainChek's software-as-a-service (SaaS), artificial intelligence (AI) platform uses smart devices with cameras to accurately evaluate patients' pain levels — saving time and money for healthcare providers since different clinicians may record…

Unit 9 is a short-term incubator that is intended to bridge the gap for young companies that need space, equipment and facilities, but do not have the funding for initial capital equipment. This new space will help companies that are looking to develop innovative devices, medicines, procedures, or systems to solve a health problem or improve quality of life. Through growing industries around these activities, it will contribute to retaining businesses and talent in the West Midlands. David Coleman, CEO…

Epworth HealthCare and Bupa will offer eligible patients increased access to rehabilitation in the home as part of an extension of their contract. The partnership will support innovative models of care by expanding rehabilitation in the home beyond traditional areas such as orthopaedics to neurological and reconditioning patients Epworth Group Chief Executive Dr. Lachlan Henderson said the partnership allowed for greater choice while maintaining access to high quality care. “Innovative programs such as rehab in the home are already providing…

Sandoz recently announced the launch of a new global initiative called ‘Act4Biosimilars’ to help address health inequity and inequality worldwide. Act4Biosimilars aims to increase patient access to advanced medicines by facilitating greater approvability, accessibility, acceptability and affordability (the 4 A’s) of biosimilars. The initiative is supported by a multidisciplinary Steering Committee of patient advocacy leaders, healthcare professionals, biosimilar experts and industry leaders from around the world, with a mission to increase global adoption of biosimilar medicines by at least 30%…